Role of microenvironment and stroma in cancer therapy

Adding bevacizumab to standard first-line chemoradiation for glioblastoma gives no survival benefit

Science behind phase I clinical trials: targeting tumour cell development pathways

ASCO 2013 highlights

Crizotinib superior to chemo for advanced ALK positive NSCLC

Next generation of anti-cancer agents: data from ASCO 2013

Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery

Comment on progression free survival in lung cancer patients and the GALAXY-1 trial

Paclitaxel dosing equally effective in preventing breast cancer progression

Biennial cervical cancer screening with vinegar reduces mortality

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer